Abiopharma

(90% Positive) Corbus Pharmaceuticals Holdings Inc. (CRBP) Files Form 8-K

(95% Positive) Sotera Health Co (SHC) Announces Business Combination

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference

(85% Positive) Bicycle Therapeutics (BCYC) Provides Update on potential for an end-t

(99% Positive) Orthopediatrics Corp (KIDS) Reports Q1 2026 Financial Results

(90% Positive) Agios Pharmaceuticals Inc (AGIO) Announces Enrollment Update for anticipated Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Positive) Axogen Inc. (AXGN) Announces Business Combination

(75% Positive) NeoGenomics Inc (NEO) Reports Q1 2026 Financial Results

(99% Neutral) Axsome Therapeutics Inc (AXSM) Announces Enrollment Update for revenues Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process

(75% Positive) TriSalus Life Sciences Inc (TLSIW) Announces Clinical Development Update

(99% Positive) Caredx Inc (CDNA) Reports Q1 2026 Financial Results

(10% Negative) Annexon Inc (ANNX) Announces Delay in milestones Trials for Autoimmune Disease Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results